The Influence of Insulin Therapy on the Course of Acute Exacerbation of Bronchial Asthma

2015 ◽  
pp. 45-51 ◽  
Author(s):  
K. Wytrychowski ◽  
A. Obojski ◽  
A. Hans-Wytrychowska
Keyword(s):  
Insulin Therapy ◽  
Acute Exacerbation ◽  
Bronchial Asthma

Atypical Pathogen Infection in Adults with Acute Exacerbation of Bronchial Asthma

2003 ◽  
Vol 167 (3) ◽  
pp. 406-410 ◽  
Author(s):  
David Lieberman ◽  
Devora Lieberman ◽  
Shmuel Printz ◽  
Miriam Ben-Yaakov ◽  
Zilia Lazarovich ◽  
...  
Keyword(s):  
Acute Exacerbation ◽  
Bronchial Asthma ◽  
Pathogen Infection ◽  
Atypical Pathogen

scholarly journals Q Fever (Coxiella burnetii infection) and Acute Exacerbation of Bronchial Asthma

2005 ◽  
Vol 44 (1) ◽  
pp. 79-80 ◽  
Author(s):  
Niro OKIMOTO ◽  
Naoko ASAOKA ◽  
Kenji YAMATO ◽  
Yoshihiro HONDA ◽  
Takeyuki KURIHARA ◽  
...  
Keyword(s):  
Acute Exacerbation ◽  
Bronchial Asthma ◽  
Coxiella Burnetii ◽  
Q Fever

scholarly journals Association between Substance Abuse and Acute Exacerbation of Bronchial Asthma

1996 ◽  
Vol 3 (12) ◽  
pp. 1170-1172 ◽  
Author(s):  
Theodore J. Gaeta ◽  
Regina Hammock ◽  
Theodore A. Spevack ◽  
Howard Brown ◽  
Karen Rhoden
Keyword(s):  
Substance Abuse ◽  
Acute Exacerbation ◽  
Bronchial Asthma

scholarly journals Inhaled budesonide versus oral prednisolone in the treatment of acute exacerbation of moderate bronchial asthma: an open label randomized clinical trial

2021 ◽  
Vol 9 (4) ◽  
pp. 1138
Author(s):  
Reashma Roshan ◽  
Mubashir H. Shah ◽  
Aejaz A. Bhat
Keyword(s):  
Clinical Trial ◽  
Randomized Clinical Trial ◽  
Acute Exacerbation ◽  
Bronchial Asthma ◽  
Inhaled Corticosteroids ◽  
Oral Prednisolone ◽  
Open Label ◽  
Oxygen Inhalation ◽  
Group B ◽  
Inhaled Budesonide

Background: Recently published studies have suggested that inhaled corticosteroids may offer benefit over systemic steroids in bronchial asthma. This research was carried out to study the efficacy of inhaled budesonide and to compare the efficacy of inhaled budesonide with oral prednisolone in the treatment of acute moderate asthma in children.Methods: This was an open label randomized clinical trial. Children in the age group of 1-12 years with acute exacerbation of asthma presenting to pediatric emergency from November 1, 2015 to October 31, 2016 who fail to show prompt improvement after initial treatment with oxygenand three doses of inhaled salbutamol, were enrolled. Children in group B (n=35) and group P (n=35) received inhaled budesonide and oral prednisolone, respectively, in addition to oxygen inhalation and salbutamol as per the study protocol. Outcome was measured in terms of pulmonary score at the beginning, at 6 hours, and at 24 hours of starting the treatment. The analysis was undertaken according to intent to treat principle.Results: Baseline characteristics (sex, age, weight, height, body mass index) were comparable in the 2 groups. Mean heart rate, respiratory rate, pulmonary score at 6 and 24 hours, mean SpO2 at 24 hours were significantly showing normalizing trend (p<0.05) and mean hospital stay was significantly reduced [2.60 (±0.60) vs 3.11 (±0.80); p<0.05] in group B as compared to group P.Conclusions: Outcome measures of clinical improvement were better in inhaled budesonide group than oral prednisolone group in acute moderate exacerbation of bronchial asthma. 

scholarly journals A retrospective study on drug utilization in patients with acute exacerbation of bronchial asthma in adults at tertiary teaching hospital in Bidar

2017 ◽  
Vol 6 (2) ◽  
pp. 389
Author(s):  
Jyothi D. B. ◽  
Gajanan P. Kulkarni
Keyword(s):  
Combination Therapy ◽  
Acute Exacerbation ◽  
Bronchial Asthma ◽  
Drug Utilization ◽  
Pulmonary Medicine ◽  
Continuous Quality ◽  
Tertiary Teaching ◽  
Acute Exacerbations ◽  
Tertiary Teaching Hospital ◽  
Β2 Agonists

Background: Drug utilization plays a role in helping the health care system to understand, interpret and improve the drug use and continuous quality improvement. It plays an essential part of pharmaco Epidemiological studies.Methods: 100 prescriptions from patients with established diagnosis of acute exacerbation of Bronchial asthma were assessed from the Department of Pulmonary Medicine and the data gathered was analysed using MS Excel.Results: Majority of the prescriptions irrespective of severity received inhalation β2 agonist (formoterol) as a bronchodilator. Nebulization route was given for managing the acute exacerbations followed by inhalation route. Hydrocortisone was prescribed to all patients for managing acute Exacerbations. Montelukast was used an adjuvant therapy. Most of them were prescribed combination therapy. Theophylline was prescribed among all the methylxanthines.Conclusions: β2 agonists Combinations and corticosteroids are the most commonly prescribed combination drugs for asthma followed by methylxanthines. The most commonly prescribed asthmatic Medication in combination therapy was inhaled salbutamol with ipratropium followed by intravenous Hydrocortisone and oral Montelukast. The most commonly prescribed methylxanthine was intravenous Theophylline. Nebulization was preferred route to tackle the acute exacerbation of asthmatic symptoms.

Sign in / Sign up

Export Citation Format

Share Document